Superficial malignant fibrous histiocytoma presenting as recurrent atypical fibroxanthoma
- 7 April 2004
- journal article
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 45 (2), 106-109
- https://doi.org/10.1111/j.1440-0960.2004.00056.x
Abstract
Atypical fibroxanthoma (AFX) and malignant fibrous histiocytoma (MFH) are neoplasms of probable fibrohistiocytic lineage. The precise relationship between AFX and MFH remains controversial. We present two cases in which a lesion was excised from the face of an elderly person and reported as AFX. Both cases recurred within 12 months and were reclassified as MFH. They were excised with slow Mohs' micrographic surgery, with adjuvant radiotherapy in one case. In the other, a further recurrence was treated with orbital exenteration and radiotherapy. We review the difficulties in differentiating between AFX and MFH and the implications for treatment.Keywords
This publication has 12 references indexed in Scilit:
- Immunoexpression of Ultraviolet Photoproducts and p53 Mutation Analysis in Atypical Fibroxanthoma and Superficial Malignant Fibrous HistiocytomaLaboratory Investigation, 2001
- Mohs micrographic surgery for the treatment of spindle cell tumors of the skinJournal of the American Academy of Dermatology, 2001
- Micrographic Surgery (‘Slow Mohs’) in Cutaneous SarcomasDermatology, 1999
- Malignant fibrous tumorsSeminars in Cutaneous Medicine and Surgery, 1998
- LN-2 (CD74)Cancer, 1997
- A Comparison of Mohs Micrographic Surgery and Wide Excision for the Treatment of Atypical FibroxanthomaDermatologic Surgery, 1997
- Atypical fibroxanthoma: DNA ploidy analysis of 14 cases with possible histogenetic implicationsJournal of Cutaneous Pathology, 1993
- Atypical fibroxanthoma of the skin.British Journal of Dermatology, 1977